JAYME DONALDSON: Open Payments
NPI 1447863626 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 57 payments from 7 companies in 2025. Trend: 2023 $489 · 2024 $470 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $273 |
| ABBVIE INC. | 19 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $194 |
| Otsuka America Pharmaceutical, Inc. | 7 | $180 |
| Neurocrine BioSciences, Inc. | 8 | $162 |
| Supernus Pharmaceuticals, Inc. | 2 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, ABILIFY MAINTENA, Qelbree, ABILIFY ASIMTUFII, VIVITROL.
Industry payments across WY — which companies pay providers there.
